CAEN, France

Matthieu Meryet-figuiere


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthieu Meryet-Figuiere: Innovator in Ovarian Carcinoma Research

Introduction

Matthieu Meryet-Figuiere is a notable inventor based in Caen, France. He has made significant contributions to the field of medical research, particularly in the area of ovarian carcinoma. His work focuses on the identification of biomarkers that can aid in the diagnosis and prognosis of high-grade serous ovarian carcinoma.

Latest Patents

Meryet-Figuiere holds a patent titled "Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care." This patent relates to the identification of a circulating miRNA biomarker that is suitable for use in diagnosing and prognosticating high-grade serous ovarian carcinoma (HGSOC). The patent also includes the development of diagnostic kits for such purposes. He has 1 patent to his name.

Career Highlights

Throughout his career, Matthieu Meryet-Figuiere has worked with esteemed institutions such as Université de Caen Normandie and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding of ovarian cancer and improving therapeutic care options.

Collaborations

Meryet-Figuiere has collaborated with notable colleagues, including Nicolas Vigneron and Christophe Denoyelle. These partnerships have contributed to the success of his research endeavors.

Conclusion

Matthieu Meryet-Figuiere is a distinguished inventor whose work in ovarian carcinoma research has the potential to significantly impact diagnostic and therapeutic practices. His contributions to the field are invaluable and continue to inspire further innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…